Teder H, Christensson P I, Aronsen K F, Lewan L, Ljungberg J, Stenram U
Res Exp Med (Berl). 1985;185(5):405-14. doi: 10.1007/BF01851921.
The effects of hepatic artery administration of degradable starch microspheres on liver energy charge and nucleic acid anabolism were studied in rats. Liver energy charge was evaluated 20 and 60 min after the injection of degradable starch microspheres. As compared to controls the microspheres had no effect on liver energy charge. The incorporation of orotic acid, uracil, and thymidine into liver RNA or DNA was studied 1 h after hepatic artery injection of precursor alone or together with degradable starch microspheres. Orotic acid and uracil incorporation into RNA was studied in normal rats and the DNA incorporation of thymidine in animals with regenerating livers. Orotic acid and thymidine were given in trace amounts. Uracil was given in amounts corresponding to a therapeutic dose of 5-fluorouracil. The addition of microspheres had no effects on the incorporation of the nucleic acid precursors into RNA or DNA. Thus, in the normal liver degradable starch microspheres administered by the hepatic artery had no influence on liver energy charge or RNA anabolism in the liver. Also the microspheres had no negative effects on the DNA anabolism in proliferating liver cells.
研究了肝动脉注射可降解淀粉微球对大鼠肝脏能量代谢和核酸合成代谢的影响。在注射可降解淀粉微球后20分钟和60分钟评估肝脏能量代谢。与对照组相比,微球对肝脏能量代谢无影响。在肝动脉注射前体单独或与可降解淀粉微球一起1小时后,研究乳清酸、尿嘧啶和胸腺嘧啶掺入肝脏RNA或DNA的情况。在正常大鼠中研究乳清酸和尿嘧啶掺入RNA的情况,在肝脏再生的动物中研究胸腺嘧啶掺入DNA的情况。乳清酸和胸腺嘧啶给予微量。尿嘧啶给予的量相当于5-氟尿嘧啶的治疗剂量。微球的添加对核酸前体掺入RNA或DNA没有影响。因此,在正常肝脏中,通过肝动脉给药的可降解淀粉微球对肝脏能量代谢或肝脏RNA合成代谢没有影响。微球对增殖肝细胞中的DNA合成代谢也没有负面影响。